AUSTRALIAN Cancer Technology Limited is set to begin human trials of its p53 cancer vaccine, Pentrix, at St Vincent’s Hospital, Sydney, after receiving all required approvals.
02 Oct 2001
Subscribe today for award-winning, unbiased and trusted journalism
